Recce Pharmaceuticals Sponsored Session: Beyond Existing Antibiotics: Finding a Solution to AMR and Sepsis
Description:
Date/Time: April 10, 2024 | 11:50 am - 12:20 pm ET
Beyond Existing Antibiotics: Finding a Solution to AMR and Sepsis will be an exploration into the forefront of medical innovation. In this sponsored session, Recce Pharmaceuticals unveils their portfolio approach to tackling the growing threats of antimicrobial resistance (AMR) and sepsis, two critical challenges in modern healthcare. Through innovative synthetic anti-infectives, Recce's breakthrough clinical-stage technology aims to go beyond conventional antibiotics, offering a novel, broad-spectrum solution to combatting resistant strains of bacteria and addressing the urgent need for effective sepsis treatments.
Target Audience:
Nurses, advanced practice providers, physicians, emergency responders, pharmacists, medical technologists, respiratory therapists, physical/occupational therapists, infection prevention specialists, data/quality specialists, and more.
James Graham
Managing Director & Chief Executive Officer
Recce Pharmaceuticals
James Graham is the Chief Executive Officer of Recce Pharmaceuticals. He was formerly Executive Director and has extensive experience in marketing, business development, and commercialization of early-stage technologies with global potential. Mr. Graham serves on Recce’s Board of Directors and has invested in almost every capital raise to date with a focus on expanding Recce’s commercial opportunities and clinical initiatives.
Summit 2024 Session: Recce Pharmaceuticals Sponsored Session: New Frontiers in Sepsis and Urosepsis Treatment: Synthetic Anti-Infectives to Combat Superbugs
Session Day/Time: Wednesday, September 25, 2024, 11:30 AM - 12:00 PM EST